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neuronal apoptosis and neurodegeneration (Allen et al., 2007; Ferrer, 2009a; Marín 26 et al., 2007; Ramírez et al., 2009) . Lipid rafts have also been implicated in β-amyloid 27 processing in Alzheimer's disease (AD) (Cordy et al., 2006; Hicks et al., 2012; 28 Vetrivel and Thinakaran, 2010) and with α-synuclein-membrane interactions in
29
Parkinson's disease (PD) (Fabelo et al., 2011; Ferrer, 2009b; Kubo et al., 2005; Park 30 et al., 2009).
31
Our previous studies have shown marked alterations in the composition of lipid rafts 32 in the frontal cortex in AD and neocortex and related models and in the frontal cortex M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 in PD at different stages of disease progression (Fabelo et al., 2011; Fabelo et al., 1 2014; Martín et al., 2010) . Although modifications in the composition of lipid rafts 2 exist in both groups of diseases, disease-specific changes occur in AD and PD. 3 For this reason, the present study is first focused on assessing the lipid composition 4 and protein redistribution in lipid rafts in the frontal cortex of DLB, and second on 5 performing a meta-analysis comparing observations in DLB, PD and AD. The latter 6 point is sustained by the fact that the same methods and the same hands performed 7 the studies in the different diseases, with the goal of identifying patterns that may 8 contribute to revealing links between PD and DLB, the main diseases of the Lewy 9 Body Disease (LBD) spectrum, and the high prevalence of AD in DLB related mainly to β-amyloid pathology.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
(clone AT8), phosphorylation-specific tau Thr181, Ser202, Ser214, Ser262, Ser396 23 and Ser422, αB-crystallin, α-synuclein, ubiquitin, p62, TDP-43 and PrP. 
Isolation of lipid rafts

28
Samples of frontal cortex area 8 grey matter were carefully dissected avoiding 29 contamination with white matter. Lipid raft fractions were isolated following the 30 protocols previously described for human brain (Fabelo et al., 2014; Martín et al., 
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6 (50mM Tris-HCl, pH 8.0, 10mM MgCl 2 , 20mM NaF, 1mM Na 3 VO 4 , 5mM β-1 mercaptoethanol, 1mM phenylmethylsulfonyl fluoride (PMSF) and a cocktail of 2 protease inhibitors (Roche Diagnostics, Barcelona, Spain) containing 1% Triton X-3 100 and 5% glycerol in a glass homogenizer grinder. Homogenates were then 4 centrifuged at 500xg for 5 min and the supernatant was collected and mixed in an 5 orbital rotor for 1 h. All steps were performed on ice or in a cold room at 4ºC. About 6 800µl of each sample was mixed with an equal volume of 80% sucrose in buffer A 7 and then over-layered with 7.5 ml of 35% sucrose solution and 2.7 ml of 15% 8 sucrose solution in homogenization buffer in 10 ml ultracentrifuge tubes (Ultraclear, 9 Beckman, Brea, CA, USA). Sucrose gradients were centrifuged at 150,000xg for 18 h 10 at 4ºC in a Beckman SW41Ti rotor. Two ml fractions were collected from the top to 11 the bottom of the ultracentrifuge tubes, and the final pellet, corresponding to the 12 precipitated detergent soluble fractions (i.e. non-raft fractions), was re-suspended in 
10
Lipids from lipid rafts were subjected to acid-catalyzed trans-methylation with 1% 11 sulfuric acid (v/v) in methanol. The resultant fatty acid methyl esters (FAME) and 12 dimethyl acetals (DMA) were purified with thin layer chromatography (TLC) and 13 quantified using a TRACE GC Ultra (Thermo Fisher Scientific, Waltham, MA, USA) 14 gas chromatograph equipped with a flame ionization detector. Helium was used as a 15 carrier gas. 
Statistical analyses
17
Comparison between Ctrl and DLB groups was assessed with Student's t-test or were detected in DLB. Changes resulted in modifications in phospholipid-cholesterol 7 ratio which was significantly increased in DLB (Table 2) .
8
In contrast, only minor changes were detected in the analyses of fatty acids in lipid 9 rafts, mainly in certain saturated and monoenoic fatty acids. Levels of saturated 15:0, 10 22:0 and 24:0, and monoenoic fatty acids, i.e. 15:1, 16:1, 17:1 and 18:1n-7, were all 11 augmented in DLB lipid rafts. However, in spite of these changes, total levels of 12 saturated and monoenoic fatty acids remained unaffected (Table 3 ).
13
The most important changes were observed in long-chain polyunsaturated fatty acids 14 (LCPUFA). Thus, levels of docosahexaenoic acid (22:6n-3, DHA) and total n-3
15
LCPUFA were significantly reduced, by more than 30%. Further, levels of the main n- controls and DLB (Figure 1 ). When applied to lipid classes we found that the two 28 principal components explained 60% of total variance (Fig. 1B) , with lyso- 
AD and PD
7
In order to perform a comparative meta-analysis of lipid rafts in the three 8 neurodegenerative diseases, we used previously published data from our 9 laboratories on PD and AD lipid rafts using the same analytical methodologies used 10 in the present study (Fabelo et al., 2011; Martín et al., 2010) . First, we used PCA to 11 determine lipid groups mainly contributing to overall variance in controls, DLB and 12 PD. We observed that using three principal components (64.43% of total variance 13 explained), the three groups could be clearly separated ( Fig. 2A) , and that the main 
Distribution of lipid raft proteins in DLB 22
We aimed to investigate whether the raft lipid alterations correlated with changes in 23 the distribution of raft integrated proteins relevant to DLB pathology (Fig. 3) . Proteins , 1986; Dexter et al., 1989; Dexter et al., 1994; Ferrer, 2009; Gómez and 11 Martínez et al., 2010; Kidd, 2000) . A reduction in cholesterol with an increase in 12 sterol esters and lyso-phosphatidylcholine is singular to DLB; these modifications are in the unsaturation and peroxidability indexes in PD compared with DLB.
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28
Reduction in the polyunsaturated n-3 and n-6 series in DLB lipid rafts likely alters the and amyloid beta toxicity (Fernández-Echevarría et al., 2014; Marín et al., 2007) . Fernandez-Echevarría, C.E., Diaz, M., Ferrer, I., Canerina-Amaro, A., Marin, R., 2014. 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Highlights:
Lipid rafts from DLB exhibit anomalous lipid contents and protein distribution Lipid rafts from DLB contain reduced levels of DHA, plasmalogens and cholesterol Lipid alterations in DLB partly overlap those observed in Alzheimer's disease Lipid alterations correlate with increased accumulation of amyloidogenic proteins Some lipid alterations in lipid rafts in DLB are common to Parkinson's disease
